Literature DB >> 22397682

Cross-ethnic measurement equivalence of the SCARED in an outpatient sample of African American and non-Hispanic White youths and parents.

Araceli Gonzalez1, V Robin Weersing, Erin Warnick, Lawrence Scahill, Joseph Woolston.   

Abstract

The present study evaluated the measurement equivalence of the Screen for Child Anxiety Related Emotional Disorders (SCARED) in a clinical sample of non-Hispanic White (NHW) and African American (AA) youths and parents. In addition, we explored the concurrent criterion validity of parent report on the SCARED to a parent diagnostic interview. Cross-ethnic measurement equivalence was examined in both youth self-report (ages 11-18; N = 374) and parent report (youth ages 5-18; N = 808) using multiple group analysis. Sensitivity, specificity, positive predictive value, and negative predictive value of the SCARED parent report were also examined. The original five-factor structure of the SCARED was replicated using confirmatory factor analysis for both groups using parent and youth report, although factor loadings were not equivalent across groups. Sensitivity and specificity of the SCARED-P clinical cutoff score (Total ≥25) to anxiety diagnoses were acceptable in both ethnic groups. Although evidence for the cross-ethnic equivalence of SCARED was limited, results suggest a similar structure of anxiety symptoms across NHW and AA youths while demonstrating sensitivity in symptom-level differences in anxiety expression. Overall, results provide preliminary evidence for the SCARED as an acceptable screening tool for anxiety symptoms in NHW and AA youths.

Entities:  

Mesh:

Year:  2012        PMID: 22397682     DOI: 10.1080/15374416.2012.654462

Source DB:  PubMed          Journal:  J Clin Child Adolesc Psychol        ISSN: 1537-4416


  8 in total

1.  Diagnostic Efficiency of Caregiver Report on the SCARED for Identifying Youth Anxiety Disorders in Outpatient Settings.

Authors:  Anna R Van Meter; Dokyoung S You; Tate Halverson; Eric A Youngstrom; Boris Birmaher; Mary A Fristad; Robert A Kowatch; Amy Storfer-Isser; Sarah M Horwitz; Thomas W Frazier; L Eugene Arnold; Robert L Findling; The Lams Group
Journal:  J Clin Child Adolesc Psychol       Date:  2016-08-02

2.  The Screen for Child Anxiety Related Emotional Disorders (SCARED): Informant Discrepancy, Measurement Invariance, and Test-Retest Reliability.

Authors:  Brigid Behrens; Caroline Swetlitz; Daniel S Pine; David Pagliaccio
Journal:  Child Psychiatry Hum Dev       Date:  2019-06

3.  Measurement equivalence of the KINDL questionnaire across child self-reports and parent proxy-reports: a comparison between item response theory and ordinal logistic regression.

Authors:  Peyman Jafari; Zahra Sharafi; Zahra Bagheri; Sara Shalileh
Journal:  Child Psychiatry Hum Dev       Date:  2014-06

4.  Bounce back: Effectiveness of an elementary school-based intervention for multicultural children exposed to traumatic events.

Authors:  Audra K Langley; Araceli Gonzalez; Catherine A Sugar; Diana Solis; Lisa Jaycox
Journal:  J Consult Clin Psychol       Date:  2015-08-24

5.  Factor Structure of the Parent-Report Mood and Feelings Questionnaire (MFQ) in an Outpatient Mental Health Sample.

Authors:  Megan Jeffreys; Michelle Rozenman; Araceli Gonzalez; Erin M Warnick; Christine Dauser; Lawrence Scahill; Joseph Woolston; V Robin Weersing
Journal:  J Abnorm Child Psychol       Date:  2016-08

6.  Using Evaluative Criteria to Review Youth Anxiety Measures, Part II: Parent-Report.

Authors:  Rebecca G Etkin; Eli R Lebowitz; Wendy K Silverman
Journal:  J Clin Child Adolesc Psychol       Date:  2021 Mar-Apr

7.  Using Evaluative Criteria to Review Youth Anxiety Measures, Part I: Self-Report.

Authors:  Rebecca G Etkin; Yaara Shimshoni; Eli R Lebowitz; Wendy K Silverman
Journal:  J Clin Child Adolesc Psychol       Date:  2020-09-11

Review 8.  Systematic review of the properties of tools used to measure outcomes in anxiety intervention studies for children with autism spectrum disorders.

Authors:  Sarah Wigham; Helen McConachie
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.